SCHEMBL61735

SCHEMBL61735

NC1(OC=O)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61974 0.94
SCHEMBL60474 0.92 TSHR (0.32)
SCHEMBL62222 0.92 TSHR (0.32)
Hydrochloric Acid SCHEMBL3168559 0.92
SCHEMBL61654 0.92 TSHR (0.32)
Hydrochloric Acid SCHEMBL9009933 0.90 TSHR (0.31)
SCHEMBL61083 0.88
Hydrochloric Acid SCHEMBL8681308 0.86
Hydrochloric Acid SCHEMBL5960763 0.83
SCHEMBL15380607 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 968 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120081924-A GLP-1R receptor agonistic polypeptide compounds and uses thereof 中国药科大学 2025-06-03 CN claimed
US-20250122239-A1 DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE HOLST BIRGITTE (DK) 2025-04-17 US claimed
WO-2025069009-A1 ROCK2 INHIBITORS IN THE TREATMENT OF OBESITY GRAVITON BIOSCIENCE BV (NL) 2025-04-03 WO claimed
CN-119390784-A Dual-agonism polypeptide compound and medical application thereof 中国药科大学 2025-02-07 CN claimed
CN-119119207-A Phase separated polypeptide and GLP-1 RAs derivative containing same 北京化工大学 2024-12-13 CN claimed
CN-118994411-A High-stability long-acting GLP-1 RAs derivative 北京化工大学 2024-11-22 CN claimed
CN-118440155-B Dual-agonism polypeptide compound and medical application thereof 中国药科大学 2024-11-22 CN claimed
CN-118546214-A GLP-1R receptor agonistic polypeptide compounds and uses thereof 中国药科大学 2024-08-27 CN claimed
CN-118440155-A Dual-agonism polypeptide compound and medical application thereof 中国药科大学 2024-08-06 CN claimed
CN-117896914-B Surface treatment method of copper-clad printed circuit board 江苏上达半导体有限公司 2024-06-21 CN claimed
WO-2002012278-A2 PSEUDO-METALLOPROTEINS, CORRESPONDING PREPARATION AND USE AS BIOSENSORS UNIVERSITA' DEGLI STUDI DI NAPOLI 'FEDERICO II' (IT) 2002-02-14 WO claimed
EP-1124553-A1 NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER Ikonomidou, Hrissanthi (DE) 2001-08-22 EP claimed
EP-1002535-A1 New use of glutamate antagonists for the treatment of cancer Ikonomidou, Hrissanthi (DE) 2000-05-24 EP claimed
WO-2000024395-A1 NEW USE OF GLUTAMATE ANTAGONISTS FOR THE TREATMENT OF CANCER IKONOMIDOU HRISSANTHI (DE) 2000-05-04 WO claimed
US-6037490-A BORONATED 1-AMINO, 1-CARBOXYLIC ACID-CYCLOALKANE, PREFERABLY A BORONATED 1-AMINOCYCLOBUTANE CARBOXYLIC ACID; USEFUL IN BORON NEUTRAL CAPTURE THEORY (BNCT), ANTITUMOR THERAPY; METHOD OF SYNTHESIS THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2000-03-14 US claimed
WO-1998009973-A9 BORON-CONTAINING AMINO CARBOXYLIC ACID COMPOUNDS AND USES THEREOF 1998-07-30 WO claimed
WO-1998009973-A1 BORON-CONTAINING AMINO CARBOXYLIC ACID COMPOUNDS AND USES THEREOF THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1998-03-12 WO claimed
US-4833152-A Anti-hypertensive agents UNIVERSITY OF MIAMI (US) 1989-05-23 US claimed
EP-0036713-B1 ANGIOTENSIN CONVERTING ENZYME INHIBITORS UNIVERSITY OF MIAMI (US) 1984-01-18 EP claimed
EP-0036713-A2 Angiotensin converting enzyme inhibitors UNIVERSITY OF MIAMI (US) 1981-09-30 EP claimed